Exclusively Sponsored by AANS
The American Association of Neurological Surgeons exclusively sponsors The Doctors Company. AANS members receive unique benefits, including exclusive program discounts and credits.
Search
Dec 02, 2024
Foundation Announces 2024 Grant Recipients
The Doctors Company Foundation awarded three new grants in 2024.
From
The Doctor’s Advocate
February 19, 2025, JAMA Network Open
Ambient Listening—Legal and Ethical Issues
Ambient listening, which involves using AI to record and analyze conversations between clinicians and patients, is one area of early AI adoption among healthcare professionals. I. Glenn Cohen, JD; Julie Ritzman, MBA, CPHRM; and Richard F. Cahill, JD, provide a comprehensive analysis of the legal and ethical considerations associated with the use of ambient listening technologies in healthcare settings.
Feb 21, 2023
Risk Management Fundamentals for the Practice Manager
Our complimentary program is exclusive to all member practice managers, both clinical and nonclinical, who are new to the role or seek further education regarding the application of risk management and patient safety measures (or principles) in an office-based medical or dental practice.
March 01, 2024, Healthcare Risk Management
AI Creates Liability Risks for Healthcare Organizations
Sue Boisvert, BSN, MHSA, CPPS, CPHRM, DFASHRM, Senior Patient Safety Risk Manager, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, discusses how artificial intelligence (AI) is becoming more common in healthcare, and while it offers substantial benefits, there are serious risks to consider.
The Doctors Company Announces $15.1 Million Dividend
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today that it has approved a 2025 premium dividend of approximately $15.1 million, bringing the total of declared dividends to date to $485 million.
Artificial Intelligence and the Future of Healthcare
This video series explores how artificial intelligence (AI) will change the future of healthcare. Eric Topol, MD, cardiologist, founder and director of The Scripps Research Translational Institute, and author of “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again," offers unique insight on how AI can return the humanity to medicine and strengthen the patient-physician relationship.
Professional Education
Delayed, Wrong, or Missed: Diagnostic Process Failure in Nurse Practitioner Practice
Diagnostic process failure resulting in delayed, wrong, or missed diagnoses has been identified as a serious and often preventable harm in healthcare. To prevent diagnostic error, nurse practitioners (NPs) should be aware of the most misdiagnosed conditions and understand the risks associated with cognitive bias. This course will help NPs understand the 12-step diagnostic process of care framework and determine where contributing factors exist in their primary practice setting to effectively recognize and implement appropriate improvement strategies.
Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
